Phase 2 Clinical Trial of CartiLife® in the United States

Clinical trial NCT04744402 · RECRUITING

Trial details

NCT number: NCT04744402
Sponsor: Biosolution Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Articular Cartilage Defect Articular Cartilage Degeneration

Start date: 2020-10-28
Primary completion: 2023-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.